Terminated PHASE3 INTERVENTIONAL 2-arm NCT01777737

Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole (TriSulfa-FPI)

Pilot Study Phase III to Evaluate the Efficacy and Safety of Trimethoprim-sulfamethoxazole in the Treatment of Idiopathic Pulmonary Fibrosis

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Conditions Idiopathic Pulmonary Fibrosis

Interventions Cotrimoxazole Placebo

Updated 8 times since 2017 Last updated: Nov 13, 2017 Started: Nov 25, 2013 Primary completion: Nov 5, 2015 Completion: Nov 5, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Changes in standards of care

Other terminated trials from Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

See all terminations from Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Other Idiopathic Pulmonary Fibrosis trials with similar outcome

Browse all Idiopathic Pulmonary Fibrosis trials

This PHASE3 trial investigates Idiopathic Pulmonary Fibrosis and is currently terminated or withdrawn. Fundación Pública Andaluza para la gestión de la Investigación en Sevilla leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Dec 2017 — Jun 2018 [monthly]

Terminated PHASE3

Status: Unknown Status → Terminated
May 2017 — Dec 2017 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2017 — May 2017 [monthly]

Recruiting PHASE3

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Junta de Andalucia

Data source: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seville, Spain